Gutfix 8 Licap Capsule

Gutfix 8 Licap Capsule সম্পর্কে

Gutfix 8 Licap Capsule একটি ক্যাপসুল ঔষধ, যার জেনেরিক নাম Lubiprostone এবং শক্তি ৮ mcg। Lubiprostone-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। এই ব্র্যান্ডের প্রস্তুতকারক Square Pharmaceuticals PLC। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।

Lubiprostone-এর ৪টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত।

Gutfix 8 Licap Capsule কী?

Gutfix 8 Licap is a capsule from Square Pharmaceuticals PLC. containing lubiprostone 8 mcg. Lubiprostone works locally in the intestine by activating chloride channels, which increases fluid secretion into the bowel and helps intestinal movement, aiding the passage of stool. It is used in adults for irritable bowel syndrome with constipation, chronic idiopathic constipation, and opioid-induced constipation in people with chronic non-cancer pain. Because it acts in the gut rather than throughout the body, its effect is focused on the digestive tract. The dose and course are decided by the doctor.

Gutfix 8 Licap-এর ব্যবহার

Gutfix 8 Licap is used in adults for three constipation-related conditions: irritable bowel syndrome with constipation, chronic idiopathic constipation, and opioid-induced constipation in patients with chronic, non-cancer pain. It helps by increasing fluid secretion in the intestine and supporting intestinal movement, which assists the passage of stool. Only a doctor can confirm whether it suits a particular person.

Gutfix 8 Licap কীভাবে ব্যবহার করবেন

Gutfix 8 Licap is a capsule taken by mouth. The doctor decides the dose, how often it is taken and how long the course lasts, and these instructions should be followed exactly. Taking the capsule with food and water may help reduce nausea. Do not change the dose on your own. If a dose is missed or you are unsure about timing, ask your doctor or pharmacist.

Gutfix 8 Licap-এর পার্শ্বপ্রতিক্রিয়া

Common side effects include diarrhea, nausea, stomach pain, and a full or bloated feeling or pressure in the stomach, along with swelling of the abdominal area. Some people may experience shortness of breath. Diarrhea can sometimes be significant. Tell your doctor if side effects are troublesome or do not settle, and seek medical advice if they are severe.

সতর্কতা ও নিরাপত্তা

Gutfix 8 Licap should not be used by people with known or suspected mechanical gastrointestinal obstruction. It is not prescribed for patients with severe diarrhea. A thorough evaluation is needed to rule out bowel obstruction before starting treatment. Nausea may occur, and taking the capsule with food may ease it. It is pregnancy category C, and it is not known whether it passes into breast milk; breastfed infants should be watched for diarrhea. Ask your doctor before use if you are pregnant, breastfeeding, or have liver problems.

সাধারণ প্রশ্ন

Is Gutfix 8 Licap safe in pregnancy or breastfeeding?

It is pregnancy category C, so it should only be used in pregnancy if the doctor decides it is appropriate. It is not known whether it passes into breast milk, and breastfed babies should be monitored for diarrhea. Always ask your doctor before using it if you are pregnant or breastfeeding.

What is Gutfix 8 Licap used for and what kind of medicine is it?

It is a laxative-type preparation containing lubiprostone. It is used in adults for irritable bowel syndrome with constipation, chronic idiopathic constipation, and opioid-induced constipation in people with chronic non-cancer pain. It works in the intestine to increase fluid secretion and support bowel movement.

What does the generic name lubiprostone mean?

Lubiprostone is the generic name of the active ingredient. It is a locally acting chloride-channel activator, meaning it works in the intestine by activating chloride channels to increase intestinal secretion and movement. The brand name Gutfix 8 Licap is simply the product name for this ingredient.

Who should ask a doctor before taking Gutfix 8 Licap?

Anyone with known or suspected bowel obstruction, severe diarrhea, liver problems, or who is pregnant or breastfeeding should speak to a doctor first. The doctor will decide whether it is suitable, the dose, and the length of the course.

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Lubiprostone is indicated in:
  • Irritable Bowel Syndrome with Constipation (IBS-C).
  • Chronic Idiopathic Constipation (CIC) in adults.
  • Opioid-Induced Constipation (OIC) in adult patients with chronic, non-cancer pain.

ফার্মাকোলজি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Lubiprostone is a locally-acting chloride-channel activator that increases intestinal secretion. In doing so, it increases intestinal motility, thus aiding the passage of stool and relieve the symptoms associated with chronic idiopathic constipation.

Lubiprostone acts by specifically activating ClC-2 chloride channels, which is a normal constituent of the apical membrane of the human intestine, in a protein kinase A action independent fashion. Activation of ClC-2 chloride channels causes an efflux of chloride ions into the lumen, which in turn leads to an efflux of sodium ions through a paracellular pathway to maintain isoelectric neutrality. As a result, water follows sodium into the lumen in order to maintain isotonic equilibrium, thereby increasing intestinal fluid secretion. By increasing intestinal fluid secretion, lubiprostone increases motility in the intestine, thereby increasing the passage of stool and alleviating symptoms associated with chronic idiopathic constipation. Activation of ClC-2 chloride channels may also stimulate the recovery of muscosal barrier function by restoring tight junction protein complexes in the intestine. Patch clamp cell studies in human cell lines have indicated that the majority of the beneficial biological activity of lubiprostone and its metabolites is observed only on the apical (luminal) portion of the gastrointestinal epithelium.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Irritable Bowel Syndrome with Constipation: The recommended dose is 8 mcg twice daily orally with food and water.

Dosage in patients with hepatic impairment: Dosage adjustment is not required for patients with moderately impaired hepatic function. For patients with severely impaired hepatic function, the recommended starting dose is 8 mcg once daily. If tolerated then dose can be increased to 8 mcg twice 

Chronic Idiopathic Constipation and Opioid-induced Constipation: The recommended dose is 24 mcg twice daily orally with food and water. 

Dosage in patients with hepatic impairment: For patients with moderately impaired hepatic function, the recommended starting dose is 16 mcg twice daily. For patients with severely impaired hepatic function, the recommended starting dose is 8 mcg twice daily.

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

There is a possibility of a dose-dependent decrease in the efficacy of Lubiprostone in patients using diphenylheptane opioids.

প্রতিনির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Lubiprostone is contraindicated in patients with known or suspected mechanical gastrointestinal obstruction.

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Diarrhea, full or bloated feeling or pressure in the stomach, nausea, stomach pain, swelling of abdominal or stomach area, Dyspnea

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Pregnancy category C. It is not known whether lubiprostone is excreted in human milk. Because lubiprostone increases fluid secretion in the intestine and intestinal motility, human milk-fed infants should be monitored for diarrhea. Caution should be exercised when Lubiprostone is administered to a nursing woman.

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Nausea: Patients taking Lubiprostone may experience nausea. Concomitant administration of food with Lubiprostone may reduce symptoms of nausea.

Diarrhea: Lubistone should not be prescribed to patients that have severe diarrhea.

Bowel Obstruction: In patients with symptoms suggestive of mechanical gastrointestinal obstruction, perform a thorough evaluation to confirm the absence of an obstruction prior to initiating therapy with Lubiprostone.

মাত্রাধিক্যতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Adverse reactions due to overdose may include: nausea, diarrhea, vomiting, dizziness, headache, abdominal pain, flushing/hot flash, retching, dyspnea, pallor, stomach discomfort, anorexia, asthenia , chest discomfort, dry mouth, hyperhidrosis , and syncope.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Store between 15-30° C.

বিকল্প ব্র্যান্ড: Lubiprostone

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।